The Penta investment group posted a record net profit of CZK 15.6 billion in 2024, marking a 29% increase compared to the previous year and the highest earnings in the company’s history since its establishment in 1994. The strong financial performance was driven primarily by its pharmacy chain Dr. Max, alongside contributions from other key segments including healthcare, betting, banking, and real estate.
According to figures released by Penta today, the group achieved a return of 16.1% last year. Its total consolidated turnover reached CZK 274.2 billion, a year-on-year rise of approximately 25%. The company also paid CZK 20.2 billion in taxes and levies in 2024.
Dr. Max remained the largest contributor to Penta’s profits, followed by the Fortuna Entertainment Group, the Penta Hospitals network, financial services, and real estate developments. Penta Real Estate, a major player in the group’s portfolio, currently manages assets worth nearly CZK 43 billion.
“We significantly strengthened our position in healthcare and social services in the Czech Republic last year,” said Penta co-founder Marek Dospiva. “Penta Real Estate continues to play a key role in transforming Prague and Bratislava into modern metropolises and is now preparing for expansion into the London market.”
In a major strategic shift, Penta opened its fund to qualified investors at the end of 2024. According to Dospiva, the group exceeded its annual fundraising target within the first two months of the initiative.
Penta, founded by Marek Dospiva and Jaroslav Haščák in September 1994, is a Central European investment group operating in more than ten countries. It focuses on long-term investments across retail, healthcare, real estate, financial services, manufacturing, and media. The group currently employs over 50,000 people and maintains key offices in Prague, Bratislava, Warsaw, and Cyprus.
Source: CTK